Skip to main content
Top
Published in: Acta Neuropathologica 2/2016

Open Access 01-08-2016 | Original Paper

The importance of nerve microenvironment for schwannoma development

Authors: Alexander Schulz, Robert Büttner, Christian Hagel, Stephan L. Baader, Lan Kluwe, Johannes Salamon, Victor-Felix Mautner, Thomas Mindos, David B. Parkinson, Jeffrey R. Gehlhausen, D. Wade Clapp, Helen Morrison

Published in: Acta Neuropathologica | Issue 2/2016

Login to get access

Abstract

Schwannomas are predominantly benign nerve sheath neoplasms caused by Nf2 gene inactivation. Presently, treatment options are mainly limited to surgical tumor resection due to the lack of effective pharmacological drugs. Although the mechanistic understanding of Nf2 gene function has advanced, it has so far been primarily restricted to Schwann cell-intrinsic events. Extracellular cues determining Schwann cell behavior with regard to schwannoma development remain unknown. Here we show pro-tumourigenic microenvironmental effects on Schwann cells where an altered axonal microenvironment in cooperation with injury signals contribute to a persistent regenerative Schwann cell response promoting schwannoma development. Specifically in genetically engineered mice following crush injuries on sciatic nerves, we found macroscopic nerve swellings in mice with homozygous nf2 gene deletion in Schwann cells and in animals with heterozygous nf2 knockout in both Schwann cells and axons. However, patient-mimicking schwannomas could only be provoked in animals with combined heterozygous nf2 knockout in Schwann cells and axons. We identified a severe re-myelination defect and sustained macrophage presence in the tumor tissue as major abnormalities. Strikingly, treatment of tumor-developing mice after nerve crush injury with medium-dose aspirin significantly decreased schwannoma progression in this disease model. Our results suggest a multifactorial concept for schwannoma formation—emphasizing axonal factors and mechanical nerve irritation as predilection site for schwannoma development. Furthermore, we provide evidence supporting the potential efficacy of anti-inflammatory drugs in the treatment of schwannomas.
Appendix
Available only for authorised users
Literature
2.
go back to reference Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76CrossRefPubMed Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76CrossRefPubMed
4.
go back to reference Bauder AR, Ferguson TA (2012) Reproducible mouse sciatic nerve crush and subsequent assessment of regeneration by whole mount muscle analysis. J Vis Exp JoVE. doi:10.3791/3606 PubMed Bauder AR, Ferguson TA (2012) Reproducible mouse sciatic nerve crush and subsequent assessment of regeneration by whole mount muscle analysis. J Vis Exp JoVE. doi:10.​3791/​3606 PubMed
5.
go back to reference Boin A, Couvelard A, Couderc C, Brito I, Filipescu D, Kalamarides M, Bedossa P, De Koning L, Danelsky C, Dubois T et al (2014) Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas. Neuro-oncology 16:1196–1209. doi:10.1093/neuonc/nou020 CrossRefPubMedPubMedCentral Boin A, Couvelard A, Couderc C, Brito I, Filipescu D, Kalamarides M, Bedossa P, De Koning L, Danelsky C, Dubois T et al (2014) Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas. Neuro-oncology 16:1196–1209. doi:10.​1093/​neuonc/​nou020 CrossRefPubMedPubMedCentral
7.
go back to reference Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, Pumiglia K, Gallick GE, Price JE (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 65:6493–6497. doi:10.1158/0008-5472.CAN-04-1303 CrossRefPubMed Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, Pumiglia K, Gallick GE, Price JE (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 65:6493–6497. doi:10.​1158/​0008-5472.​CAN-04-1303 CrossRefPubMed
11.
go back to reference de Vries M, Hogendoorn PC, Briaire-de Bruyn I, Malessy MJ, van der Mey AG (2012) Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas. Virchows Archiv Int J Pathol 460:629–636. doi:10.1007/s00428-012-1236-9 CrossRef de Vries M, Hogendoorn PC, Briaire-de Bruyn I, Malessy MJ, van der Mey AG (2012) Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas. Virchows Archiv Int J Pathol 460:629–636. doi:10.​1007/​s00428-012-1236-9 CrossRef
12.
go back to reference Feltri ML, D’Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L (1999) P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann N Y Acad Sci 883:116–123CrossRefPubMed Feltri ML, D’Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L (1999) P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann N Y Acad Sci 883:116–123CrossRefPubMed
13.
go back to reference Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, Menon K, Lajiness JD, Mwanthi M, Yang X et al (2014) A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. Hum Mol Genet. doi:10.1093/hmg/ddu414 PubMedPubMedCentral Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, Menon K, Lajiness JD, Mwanthi M, Yang X et al (2014) A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. Hum Mol Genet. doi:10.​1093/​hmg/​ddu414 PubMedPubMedCentral
14.
go back to reference Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617–1630PubMedPubMedCentral Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617–1630PubMedPubMedCentral
15.
go back to reference Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG (2010) Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:6216–6221. doi:10.1038/onc.2010.363 CrossRefPubMed Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG (2010) Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:6216–6221. doi:10.​1038/​onc.​2010.​363 CrossRefPubMed
16.
go back to reference Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF (2002) Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol 104:179–187. doi:10.1007/s00401-002-0535-7 CrossRefPubMed Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF (2002) Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol 104:179–187. doi:10.​1007/​s00401-002-0535-7 CrossRefPubMed
17.
go back to reference Hirasawa M, Cho A, Sreenath T, Sauer B, Julien JP, Kulkarni AB (2001) Neuron-specific expression of Cre recombinase during the late phase of brain development. Neurosci Res 40:125–132CrossRefPubMed Hirasawa M, Cho A, Sreenath T, Sauer B, Julien JP, Kulkarni AB (2001) Neuron-specific expression of Cre recombinase during the late phase of brain development. Neurosci Res 40:125–132CrossRefPubMed
18.
go back to reference Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T (2003) Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol Off J U St Can Acad Pathol Inc 16:293–298. doi:10.1097/01.MP.0000062654.83617.B7 Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T (2003) Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol Off J U St Can Acad Pathol Inc 16:293–298. doi:10.​1097/​01.​MP.​0000062654.​83617.​B7
20.
go back to reference Kandathil CK, Dilwali S, Wu CC, Ibrahimov M, McKenna MJ, Lee H, Stankovic KM (2014) Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 35:353–357. doi:10.1097/MAO.0000000000000189 CrossRef Kandathil CK, Dilwali S, Wu CC, Ibrahimov M, McKenna MJ, Lee H, Stankovic KM (2014) Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 35:353–357. doi:10.​1097/​MAO.​0000000000000189​ CrossRef
21.
24.
go back to reference Lassaletta L, Torres-Martin M, Pena-Granero C, Roda JM, Santa-Cruz-Ruiz S, Castresana JS, Gavilan J, Rey JA (2013) NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 34:1355–1361. doi:10.1097/MAO.0b013e318298ac79 CrossRef Lassaletta L, Torres-Martin M, Pena-Granero C, Roda JM, Santa-Cruz-Ruiz S, Castresana JS, Gavilan J, Rey JA (2013) NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 34:1355–1361. doi:10.​1097/​MAO.​0b013e318298ac79​ CrossRef
26.
27.
go back to reference Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555CrossRefPubMed Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555CrossRefPubMed
28.
29.
go back to reference Mautner VF, Nguyen R, Kutta H, Fuensterer C, Bokemeyer C, Hagel C, Friedrich RE, Panse J (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro-oncology 12:14–18. doi:10.1093/neuonc/nop010 CrossRefPubMed Mautner VF, Nguyen R, Kutta H, Fuensterer C, Bokemeyer C, Hagel C, Friedrich RE, Panse J (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro-oncology 12:14–18. doi:10.​1093/​neuonc/​nop010 CrossRefPubMed
30.
go back to reference McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121–1133CrossRefPubMedPubMedCentral McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121–1133CrossRefPubMedPubMedCentral
31.
go back to reference Mills CD (2012) M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 32:463–488CrossRefPubMed Mills CD (2012) M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 32:463–488CrossRefPubMed
32.
go back to reference Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968–980. doi:10.1101/gad.189601 CrossRefPubMedPubMedCentral Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968–980. doi:10.​1101/​gad.​189601 CrossRefPubMedPubMedCentral
34.
go back to reference Mueller M, Leonhard C, Wacker K, Ringelstein EB, Okabe M, Hickey WF, Kiefer R (2003) Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab Investig J Tech Methods Pathol 83:175–185CrossRef Mueller M, Leonhard C, Wacker K, Ringelstein EB, Okabe M, Hickey WF, Kiefer R (2003) Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab Investig J Tech Methods Pathol 83:175–185CrossRef
39.
go back to reference Parrinello S, Noon LA, Harrisingh MC, Wingfield Digby P, Rosenberg LH, Cremona CA, Echave P, Flanagan AM, Parada LF, Lloyd AC (2008) NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F. Genes Dev 22:3335–3348. doi:10.1101/gad.490608 CrossRefPubMedPubMedCentral Parrinello S, Noon LA, Harrisingh MC, Wingfield Digby P, Rosenberg LH, Cremona CA, Echave P, Flanagan AM, Parada LF, Lloyd AC (2008) NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F. Genes Dev 22:3335–3348. doi:10.​1101/​gad.​490608 CrossRefPubMedPubMedCentral
40.
44.
go back to reference Schneider J, Warzok R, Schreiber D, Guthert H (1983) Tumors of the central nervous system in biopsy and autopsy material. 7th communication: neurinomas and neurofibromatoses with CNS involvement. Zentralblatt fur allgemeine Pathologie u pathologische Anatomie 127:305–314PubMed Schneider J, Warzok R, Schreiber D, Guthert H (1983) Tumors of the central nervous system in biopsy and autopsy material. 7th communication: neurinomas and neurofibromatoses with CNS involvement. Zentralblatt fur allgemeine Pathologie u pathologische Anatomie 127:305–314PubMed
45.
go back to reference Schulz A, Baader SL, Niwa-Kawakita M, Jung MJ, Bauer R, Garcia C, Zoch A, Schacke S, Hagel C, Mautner VF et al (2013) Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat Neurosci. doi:10.1038/nn.3348 Schulz A, Baader SL, Niwa-Kawakita M, Jung MJ, Bauer R, Garcia C, Zoch A, Schacke S, Hagel C, Mautner VF et al (2013) Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat Neurosci. doi:10.​1038/​nn.​3348
47.
go back to reference Schulz A, Kyselyova A, Baader SL, Jung MJ, Zoch A, Mautner VF, Hagel C, Morrison H (2014) Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling. Brain J Neurol 137:420–432. doi:10.1093/brain/awt327 CrossRef Schulz A, Kyselyova A, Baader SL, Jung MJ, Zoch A, Mautner VF, Hagel C, Morrison H (2014) Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling. Brain J Neurol 137:420–432. doi:10.​1093/​brain/​awt327 CrossRef
49.
go back to reference Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN (1998) Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2. J Neuropathol Exp Neurol 57:1164–1167CrossRefPubMed Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN (1998) Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2. J Neuropathol Exp Neurol 57:1164–1167CrossRefPubMed
50.
go back to reference Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G et al (2004) Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 64:3718–3724. doi:10.1158/0008-5472.CAN-03-4079 CrossRefPubMed Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G et al (2004) Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 64:3718–3724. doi:10.​1158/​0008-5472.​CAN-03-4079 CrossRefPubMed
51.
go back to reference Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN (1997) Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 151:1649–1654PubMedPubMedCentral Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN (1997) Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 151:1649–1654PubMedPubMedCentral
52.
go back to reference Stivaros SM, Stemmer-Rachamimov AO, Alston R, Plotkin SR, Nadol JB, Quesnel A, O’Malley J, Whitfield GA, McCabe MG, Freeman SR et al (2015) Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2. J Med Genet. doi:10.1136/jmedgenet-2015-103050 PubMedPubMedCentral Stivaros SM, Stemmer-Rachamimov AO, Alston R, Plotkin SR, Nadol JB, Quesnel A, O’Malley J, Whitfield GA, McCabe MG, Freeman SR et al (2015) Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2. J Med Genet. doi:10.​1136/​jmedgenet-2015-103050 PubMedPubMedCentral
54.
go back to reference Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002) Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci Off J Soc Neurosci 22:6696–6703 Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002) Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci Off J Soc Neurosci 22:6696–6703
55.
go back to reference Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75:826CrossRefPubMed Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75:826CrossRefPubMed
56.
go back to reference Velanac V, Unterbarnscheidt T, Hinrichs W, Gummert MN, Fischer TM, Rossner MJ, Trimarco A, Brivio V, Taveggia C, Willem M et al (2012) Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia 60:203–217. doi:10.1002/glia.21255 CrossRefPubMed Velanac V, Unterbarnscheidt T, Hinrichs W, Gummert MN, Fischer TM, Rossner MJ, Trimarco A, Brivio V, Taveggia C, Willem M et al (2012) Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia 60:203–217. doi:10.​1002/​glia.​21255 CrossRefPubMed
Metadata
Title
The importance of nerve microenvironment for schwannoma development
Authors
Alexander Schulz
Robert Büttner
Christian Hagel
Stephan L. Baader
Lan Kluwe
Johannes Salamon
Victor-Felix Mautner
Thomas Mindos
David B. Parkinson
Jeffrey R. Gehlhausen
D. Wade Clapp
Helen Morrison
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Acta Neuropathologica / Issue 2/2016
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-016-1583-8

Other articles of this Issue 2/2016

Acta Neuropathologica 2/2016 Go to the issue